Dualsystems Biotech
Schlieren · Founded 2000
About Dualsystems Biotech
Dualsystems Biotech is a Swiss biotech company founded in 2000. Dualsystems successfully introduced yeast 2-hybrid technologies to the market and has been the leader in broadening its fields of application. In recent years the mass spectrometry-based proteomics technologies have become a major pillar of the company’s expertise. The company now exclusively focuses on its mass spectrometry-based CaptiVate and CaptiRec technologies. During two financing rounds in 2000 and in 2007 Dualsystems Biotech has built a solid investor base including private individuals as well as institutional investors to support our technology driven growth strategy.
Company Facts
- Founded: 2000
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $310.0K
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2013)
- Website: dualsystems.com
- Phone: +41 44 738 50 00
Social Profiles
Canonical: https://fsome.com/organization/dualsystems-biotech-8338314 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.